Jamil Khurram bought GALT
June 26, 2026 · Form 4 insider transaction
Jamil Khurram bought 2,533 shares of Galectin Therapeutics Inc. at $2.50 per share, a transaction worth $6.3K. The trade was recorded as option exercise under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
2,533
Price
$2.50
Total value
$6.3K
InsiderJamil Khurram
RoleOfficer
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 26, 2026
Filing dateJune 30, 2026
Shares owned after2,533
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction was made pursuant to a Rule 10b5-1 plan adopted by the reporting person on February 2, 2026, as disclosed in the Issuers Quarterly Report on Form 10-Q, filed with the SEC on May 15, 2026